Anivance Patents

Patent portfolio assigned to Anivance (verified via public assignee records). Anivance AI (Hsinchu, Taiwan; founded 2021); AI + organ-on-chip / microphysiological systems for preclinical drug testing. Confirmed patent assignee on US11795437B2 (human pulmonary alveolar epithelial cell cultivation). Third-party profiles claim 25+ patents but exact count not independently verified, so left null. Competitors per Tracxn. No named customers disclosed on own site.